<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="178">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04337281</url>
  </required_header>
  <id_info>
    <org_study_id>Highdosevitcincovid19</org_study_id>
    <nct_id>NCT04337281</nct_id>
  </id_info>
  <brief_title>Evaluation of the Effect of High-dose Vitamin C Use in Covid 19 Positive Pregnants</brief_title>
  <official_title>High-dose Vitamin C Use in Covid 19 Positive Pregnants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kanuni Sultan Suleyman Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kanuni Sultan Suleyman Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of the effect of high-dose vitamin C use in covid 19 positive pregnants
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Researchers will evaluate the change of peripheral blood values in pregnant women receiving
      high doses of vitamin c (7.5g); (hemogram, biochemistry (ast- sub-urea, creatinine,
      potassium, sodium, calcium, magnesium, vitamin d, homocysteine, ggt, crp)
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 1, 2020</start_date>
  <completion_date type="Anticipated">May 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 28, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Months</target_duration>
  <primary_outcome>
    <measure>evaluation of the change of peripheral blood values in pregnant women receiving high doses of vitamin C</measure>
    <time_frame>2 months</time_frame>
    <description>hemogram, biochemistry (ast- sub-urea, creatinine, potassium, sodium, calcium, magnesium, vitamin d, homocysteine, ggt, crp)</description>
  </primary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Covid19</condition>
  <condition>Pregnancy Related</condition>
  <condition>Vitamin C Deficiency</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>High dose vitamin C</intervention_name>
    <description>researchers will evaluate the change of peripheral blood values in pregnant women receiving high doses of vitamin C</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      (hemogram, biochemistry (ast- urea, creatinine, potassium, sodium, calcium, magnesium,
      vitamin d, homocysteine, ggt, crp)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Effect of high dose vitamin c (7.5gr) usage on blood values and clinical results in covid
        19 positive pregnants
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  pregnancy

          -  covid19 positive

          -  no lung disease

          -  no additional disease

          -  no vitamin C allergy

        Exclusion Criteria:

          -  Not pregnant

          -  have lung disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Pinar Yalcin Bahat</name>
      <address>
        <city>Istanbul</city>
        <state>İ̇stanbul</state>
        <zip>34000</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 5, 2020</study_first_submitted>
  <study_first_submitted_qc>April 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 7, 2020</study_first_posted>
  <last_update_submitted>April 5, 2020</last_update_submitted>
  <last_update_submitted_qc>April 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kanuni Sultan Suleyman Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Pınar Yalcin bahat</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Scurvy</mesh_term>
    <mesh_term>Ascorbic Acid Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Ascorbic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

